These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37182151)
1. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H Front Oncol; 2023; 13():1138238. PubMed ID: 37182151 [TBL] [Abstract][Full Text] [Related]
2. Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2. Yu L; Lu J; Xie N; Fang L; Chen S; Wu Y; Wang X; Li B J Cancer; 2023; 14(16):2964-2977. PubMed ID: 37859814 [TBL] [Abstract][Full Text] [Related]
3. METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the malignant behavior of breast cancer. Wang R; Gao X; Xie L; Lin J; Ren Y Cancer Metab; 2024 Jul; 12(1):22. PubMed ID: 39061113 [TBL] [Abstract][Full Text] [Related]
4. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer. Wang XK; Zhang YW; Wang CM; Li B; Zhang TZ; Zhou WJ; Cheng LJ; Huo MY; Zhang CH; He YL J Cell Mol Med; 2021 Jul; 25(14):6602-6617. PubMed ID: 34075693 [TBL] [Abstract][Full Text] [Related]
5. m Wang A; Sun Y; Wang X; Yan Z; Wang D; Zeng L; Lu Q Aging (Albany NY); 2023 Aug; 15(16):8444-8457. PubMed ID: 37647025 [TBL] [Abstract][Full Text] [Related]
6. METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis. Ye F; Wu J; Zhang F Biochem Biophys Res Commun; 2023 Jan; 638():1-6. PubMed ID: 36434904 [TBL] [Abstract][Full Text] [Related]
7. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression. Liu N; Zhang J; Chen W; Ma W; Wu T J Exp Clin Cancer Res; 2023 Oct; 42(1):263. PubMed ID: 37817227 [TBL] [Abstract][Full Text] [Related]
8. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987 [TBL] [Abstract][Full Text] [Related]
9. METTL16 inhibits differentiation and promotes proliferation and slow myofibers formation in chicken myoblasts. Liu Y; Shan Y; Pang L; Tang Y; Zhang M; Tu Y; Ji G; Ju X; Jiang H; Xie B; Shi S; Shu J Poult Sci; 2024 Dec; 103(12):104384. PubMed ID: 39418792 [TBL] [Abstract][Full Text] [Related]
10. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/ Li C; Liu J; Lyu Y; Ling S; Luo Y Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399 [TBL] [Abstract][Full Text] [Related]
11. Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H Front Oncol; 2023; 13():1218781. PubMed ID: 37274238 [TBL] [Abstract][Full Text] [Related]
12. METTL16-mediated translation of Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J PeerJ; 2022; 10():e14379. PubMed ID: 36518278 [TBL] [Abstract][Full Text] [Related]
13. METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway. Yu H; Zhuang J; Zhou Z; Song Q; Lv J; Yang X; Yang H; Lu Q Int J Biol Sci; 2024; 20(4):1471-1491. PubMed ID: 38385084 [TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition. Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987 [TBL] [Abstract][Full Text] [Related]
15. METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. Wei W; Zhang ZY; Shi B; Cai Y; Zhang HS; Sun CL; Fei YF; Zhong W; Zhang S; Wang C; He B; Jiang GM; Wang H J Exp Clin Cancer Res; 2023 Jun; 42(1):151. PubMed ID: 37340443 [TBL] [Abstract][Full Text] [Related]
16. The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment. Zhang Z; Xie Z; Lin J; Sun Z; Li Z; Yu W; Zeng Y; Ye G; Li J; Ye F; Su Z; Che Y; Xu P; Zeng C; Wang P; Wu Y; Shen H JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795489 [TBL] [Abstract][Full Text] [Related]
17. METTL16 participates in haemoglobin H disease through m6A modification. Liao Y; Zhang F; Yang F; Huang S; Su S; Tan X; Zhong L; Deng L; Pang L PLoS One; 2024; 19(8):e0306043. PubMed ID: 39088431 [TBL] [Abstract][Full Text] [Related]
18. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668 [TBL] [Abstract][Full Text] [Related]
19. Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma. Wang P; Wang X; Zheng L; Zhuang C Front Genet; 2020; 11():540186. PubMed ID: 33133142 [TBL] [Abstract][Full Text] [Related]
20. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]